Zylox-Tonbridge Medical Technology Co., Ltd. (818)
Munich
2.20
0.00 (0.00%)
Real-time Data
06:00 AM
Day's Range
2.202.20
52 wk Range
2.002.92
Financial Statements - 818 - Zylox-Tonbridge Medical Technology Co., Ltd.
Revenue
782.47M▲ 48.3%
Net Income
100.25M▲ 227.3%Net Margin 12.8%
EBITDA
176.57M▲ 643.6%
Free Cash Flow
-17.26M▲ 81.3%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | - | 782.47M | 527.75M | 39.97M | 177.91M | 27.63M |
| Cost of Goods | - | 222.58M | 142.76M | 9.74M | 46.03M | 11.34M |
| Gross Profit | - | 559.89M | 384.98M | 30.22M | 131.88M | 16.28M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | - | 77.07M | -144.09M | -26.58M | -218.33M | -97.78M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | - | 100.25M | -78.73M | -13.58M | -199.68M | -100.46M |
| Income Tax | - | 0 | 0 | 0 | 0 | 0 |
| Net Income | - | 100.25M | -78.73M | -13.58M | -199.68M | -100.46M |
| EPS Basic | 0.7646 | 0.3101 | -0.24 | -0.34 | -0.68 | -0.310661 |
| EPS Diluted | 0.7552 | 0.3057 | -0.24 | -0.34 | -0.68 | -0.310661 |
| Basic Shares Outstanding | 319.61M | 323.32M | 328.71M | 39.52M | 2.42B | 2.66B |
| Diluted Shares Outstanding | 319.61M | 323.32M | 328.71M | 39.52M | 2.42B | 2.66B |
| Ebit | - | 102.43M | -77.48M | -13.49M | -199.38M | -99.80M |
| Ebitda | - | 176.57M | -32.48M | -9.81M | -199.94M | -91.81M |
| Net Income Continuous Operations | - | 100.25M | -78.73M | -13.58M | -199.68M | -100.46M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
